Gail Maderis is a biotechnology executive with extensive experience leading both private and public organizations as well as non-profits. They served as Corporate Vice President at Genzyme Corporation from 1992 to 2003 and later became President & CEO at Five Prime Therapeutics from 2003 to 2009. Currently, Maderis chairs the Board of Directors at TMAB Therapeutics, Inc. and Antiva Biosciences, Inc., and holds multiple board positions in various biotech companies and organizations. They possess a strong network in the life sciences sector and have a fervent passion for life science entrepreneurship, focusing on advancing new treatments for patients.
This person is not in the org chart
This person is not in any teams
This person is not in any offices